What Beckley Clinical does

Beckley Clinical, Inc. is a private, founder-owned interventional psychiatry provider founded by Rock Feilding-Mellen and Josh Stevens to treat adults with major depression, treatment-resistant depression, PTSD, and Bipolar II who have not responded to first- and second-line treatments. The clinical model is built around rapid-acting interventional psychiatry — specifically Spravato (esketamine), racemic ketamine, and Transcranial Magnetic Stimulation (TMS) — delivered within a four-stage coordinated care pathway (Assessment, Intervention, Maintenance, Outcomes) with continuous validated outcome measurement (PHQ-9, GAD-7, PCL-5, HAM-D, MADRS) and a behavioral health home continuation layer. Services are delivered in-network through a flagship clinic in Shavano Park, San Antonio, with a second clinic planned for Houston in late 2026, plus telehealth consultations.

The business operates an insurance-first distribution model, accepting Medicare, Medicaid, Tri-Care, ChampVA, Blue Cross Blue Shield of Texas, Aetna, Cigna, Humana, Centene, UnitedHealthcare, Baylor Scott & White, and an additional set of behavioral health network aggregators (Carelon, Optum, Multiplan, ComPsych, Claritev, PHCS, Healthsmart, Sana Benefits, TriWest, Molina, WellPoint, Imperial Health, IMS, Behavioral Health Systems). Out-of-pocket pricing exceeds $350 per hour, with sliding-scale and charitable support for hardship cases and prior authorizations handled in-house. A separate revenue stream is value-based contracting with health plans — supported by in-house actuarial capability under Chief Actuary Mark Olson, FAAA — with willingness to take risk on patient outcomes for complex behavioral health members who drive 3–6x higher healthcare costs. Patient acquisition is anchored on the Andala Health scheduling and referring-provider platform. Reported early outcomes show a 40% remission rate at six months of follow-up, with a stated 70% target at twelve months. The company is pursuing NCQA accreditation. Corporate headquarters are located in Nashua, New Hampshire (legal domicile New York).

Name

Beckley Clinical

Legal name

Beckley Clinical, Inc.

Website

https://beckleyclinical.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Interventional Psychiatry Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

• Interventional psychiatry
• Treatment-resistant depression
• Ketamine infusion therapy
• Transcranial magnetic stimulation
• Behavioral health services

Headquarters

HQ city

Nashua

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Insurance Reimbursed Clinical Services: In-network provider with major commercial and government health plans including Medicare, Medicaid, Tri-Care, Blue Cross Blue Shield of Texas, Aetna, Cigna, Humana, and Centene. Revenue generated through insurance reimbursement for interventional psychiatric treatments.
2. Value-Based Care Contracts: Value-based contracting arrangements with health plans, willing to go at risk on patient outcomes. In-house actuarial capability supports risk-sharing agreements aimed at reducing total cost of care for complex behavioral health members.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Beckley Clinical provides rapid-acting interventional psychiatry services — Spravato (esketamine), racemic ketamine infusion, and Transcranial Magnetic Stimulation (TMS) — delivered through a Coordinated Care Model that pairs interventional treatment with psychiatric management, psychotherapy, and standardized outcome measurement. The practice targets patients with treatment-resistant depression, PTSD, major depressive disorder, and Bipolar II, and also accepts physician referrals and contracts with regional commercial health plans.

Product overview

Beckley Clinical operates as a healthcare services provider offering a unified interventional psychiatry platform. The core offering combines rapid-acting treatments (Spravato/esketamine, racemic ketamine, and TMS) delivered through a coordinated four-stage care model (Assessment, Intervention, Maintenance, Outcomes tracking). Services are accessible both in-person at clinic locations and via telehealth. The company positions itself as an insurance-first provider accepting major Texas health plans, with same/next-day scheduling and treatment typically beginning within 72 hours of assessment. The care model includes ongoing behavioral health home coordination and uses validated clinical measurement instruments (PHQ-9, GAD-7, PCL-5, HAM-D, MADRS) to track progress toward remission.

Differentiator

Problem solved

Functional benefit

Products and services

• Interventional Psychiatry Services

Quantifiable outcome

• 40% remission rate at 6 months (vs. 7% standard of care)
• +3 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Andala HealthcoreStrategic or Co-development PartnerAndala Health serves as Beckley Clinical's patient scheduling and provider referral platform. Patients are directed to andalahealth.com for appointment scheduling, and referring providers use the same platform for patient referrals. This is the primary patient acquisition and referral channel integrated with clinical operations.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Field Trip Health: Field Trip Health operated interventional psychiatry clinics offering ketamine and psychedelic-assisted therapy for depression and PTSD, paralleling Beckley's clinical model of rapid-acting interventions under coordinated care. Operational status has fluctuated, but as a category-defining peer it is the closest analog to Beckley on clinic-based interventional psychiatry.
• Novamind: Novamind operates mental health clinics offering ketamine-assisted therapy and interventional psychiatric care, with research affiliations similar to Beckley's outcome-tracking approach. It is a direct peer running clinic-delivered interventional psychiatry in the same treatment-resistant depression niche.
• Neuronetics: Neuronetics manufactures the NeuroStar TMS system and supports the provider network that delivers transcranial magnetic stimulation for major depressive disorder. As the device-and-network backbone behind a key modality in Beckley's offering, it is a direct competitor at the clinic level on TMS capacity and coverage.
• Mindbloom: Mindbloom provides clinician-supervised ketamine therapy for treatment-resistant depression and anxiety, combining digital intake with in-home treatment sessions. It is a direct competitor to Beckley's esketamine/ketamine arm and overlaps on the same value-based outcome story for patients who have failed standard antidepressants.
• Brainsway: Brainsway develops and markets Deep TMS systems used by psychiatric clinics to treat depression, OCD, and PTSD. It is a direct peer through the TMS channel that Beckley uses, competing for the same clinic placement decisions and the same outcome-driven patient pools.

Emerging players

• Compass Pathways: Compass Pathways runs clinical research and provider-led treatment access for psilocybin therapy in treatment-resistant depression. It overlaps with Beckley on rapid-acting compound psychiatry and the same patient population, but is positioned more upstream as a research and clinical-trial operator.

Broad incumbents

• Lyra Health: Lyra Health is a mental health benefits platform that contracts with employers and health plans to deliver therapy, coaching, and psychiatric care across in-person and virtual channels. It is a broader incumbent competing for the same health-plan relationships that drive Beckley's value-based contracting strategy, though with a much wider portfolio of services.
• Spring Health: Spring Health is a global mental health benefits provider selling to employers and health plans with a network that includes therapy, coaching, and psychiatry. It overlaps with Beckley on the health-plan contracting motion and on the complex-behavioral-health member segment, but operates as a broad incumbent network rather than a clinic operator.
• Talkspace: Talkspace operates an online therapy and psychiatry platform serving insured and employer-sponsored populations. It is a broader incumbent that competes for the same complex-behavioral-health member that Beckley targets via value-based contracts, but does so through virtual therapy and prescribing rather than in-person interventional treatments.
• Cerebral: Cerebral is a large online mental health platform providing telehealth prescribing, therapy, and care coordination for depression, anxiety, and ADHD. It is a broader incumbent that overlaps with Beckley on the depression patient funnel and on payor contracting, though its delivery model is telehealth rather than in-clinic interventional care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beckley Clinical